Press release (Ranitidine)
The Botswana Medicines Regulatory Authority wishes to inform the public of a potential safety issue in Ranitidine containing products. The presence of nitrosamine impurity called N-nitrosodimethylamine (NDMA) has been identified in the products at low levels. NDMA is classified as a possible human carcinogen (a substance that could cause cancer) based on results of animal […]
Press Release – Ranitidine Recall
The General Public is informed that the Botswana Medicines Regulatory Authority (BOMRA) has recalled with immediate effect from the market, ALL RANITIDINE containing medicines registered for use in Botswana.